Company / Interest Expense per Share
Amphstar Pharmaceuticals, Inc. Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.56
FY2023
5-year range
$0.02 / $0.56
FY2019-FY2023
Trend
+1359.0%
vs FY2022
Sector context
#10 of 43
Health Care
What the data says
Interest Expense per Share changed +1359% YoY in FY2023, a notable deviation from the 7-year average annual change of +239%.
Based on SEC 10-K filings.
0.56 in FY2023 with a 5-year CAGR of +155.2%. Top quartile in the Health Care sector.
Increased from $0.02 to $0.56 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +312.7%
- 5-Year CAGR
- +155.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 43This company $0.56 Sector average $18.61
▼
-97.0% below sector average
Key checks
Key Insights
- Amphstar Pharmaceuticals, Inc.'s interest expense per share has grown for 4 consecutive years.
- In FY2023, interest expense per share increased 1359.0% year-over-year.
- Ranks #10 out of 43 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2019.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.56 | +1359.0% |
| FY2022 | $0.04 | +107.6% |
| FY2021 | $0.02 | +132.1% |
| FY2020 | $0.01 | +214.7% |
| FY2019 | $0.00 | -51.0% |
| FY2018 | $0.01 | -70.8% |
| FY2017 | $0.02 | -21.2% |
| FY2016 | $0.02 | +2.5% |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026